Profile data is unavailable for this security.
About the company
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
- Revenue in HKD (TTM)3.81bn
- Net income in HKD1.57bn
- Incorporated2021
- Employees1.16k
- LocationGiant Biogene Holding Co LtdShanglin Yuan 7th RoadChang'An District, No. 1855XI'AN ChinaCHN
- Websitehttp://www.xajuzi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blue Moon Group Holdings Ltd | 7.32bn | 325.31m | 12.14bn | 7.96k | 35.52 | 1.17 | 20.96 | 1.66 | 0.0583 | 0.0583 | 1.31 | 1.77 | 0.591 | 10.48 | 4.24 | 920,388.60 | 2.63 | 7.71 | 2.97 | 9.55 | 62.00 | 61.25 | 4.44 | 11.76 | 6.52 | -- | 0.0151 | 56.21 | -7.84 | 1.59 | -46.79 | -10.10 | -5.28 | -- |
Shanghai Chicmax Cosmetic Co Ltd | 4.53bn | 498.44m | 18.19bn | 1.88k | 36.48 | 8.37 | 29.99 | 4.01 | 1.25 | 1.25 | 11.38 | 5.46 | 1.34 | 2.28 | 12.14 | 2,405,744.00 | 14.72 | -- | 23.75 | -- | 72.05 | -- | 11.02 | -- | 1.49 | 25.47 | 0.0754 | -- | 56.64 | -- | 213.45 | -- | -- | -- |
Vinda International Holdings Limited | -100.00bn | -100.00bn | 28.22bn | 11.47k | -- | 2.45 | -- | -- | -- | -- | -- | 9.58 | -- | -- | -- | -- | -- | 5.03 | -- | 7.32 | -- | 31.47 | -- | 6.19 | 0.6797 | -- | 0.2757 | 37.44 | 2.99 | 6.09 | -64.14 | -17.17 | -0.9673 | -12.94 |
Hengan International Group Company Ltd | 25.69bn | 3.03bn | 31.61bn | 23.00k | 10.42 | 1.43 | 7.90 | 1.23 | 2.61 | 2.61 | 22.15 | 18.97 | 0.5758 | 3.54 | 8.72 | 1,117,054.00 | 6.80 | 7.70 | 13.18 | 15.91 | 33.70 | 37.14 | 11.81 | 14.79 | 1.18 | 10.94 | 0.4089 | 65.99 | 5.09 | 2.99 | 45.46 | -5.92 | 15.95 | -9.05 |
Xinyi Solar Holdings Ltd | 26.63bn | 4.19bn | 45.80bn | 11.06k | 10.93 | 1.43 | 7.02 | 1.72 | 0.4703 | 0.4703 | 2.99 | 3.59 | 0.4798 | 9.47 | 2.53 | 2,407,010.00 | 8.47 | 10.51 | 13.09 | 15.42 | 26.62 | 36.37 | 17.65 | 26.52 | 1.03 | 12.63 | 0.2332 | 47.74 | 29.62 | 28.26 | 9.61 | 17.58 | 26.66 | 13.02 |
L'Occitane International S.A. | 19.53bn | 739.32m | 47.93bn | 9.18k | 64.80 | 6.28 | 22.41 | 2.45 | 0.5015 | 0.5015 | 13.25 | 5.17 | 0.7678 | 1.34 | 8.32 | 2,244,373.00 | 3.13 | 6.26 | 4.28 | 8.54 | 79.60 | 81.96 | 4.07 | 8.76 | 0.6846 | 5.97 | 0.4545 | 35.30 | 19.83 | 10.10 | -52.44 | 3.63 | -11.34 | 1.44 |
Giant Biogene Holding Co Ltd | 3.81bn | 1.57bn | 50.85bn | 1.16k | 30.89 | 10.43 | 31.73 | 13.35 | 1.60 | 1.60 | 3.88 | 4.74 | -- | -- | -- | 3,272,736.00 | -- | -- | -- | -- | 83.63 | -- | 41.09 | -- | 7.42 | -- | 0.0006 | -- | 49.05 | -- | 44.88 | -- | -- | -- |
Smoore International Holdings Ltd | 12.07bn | 1.78bn | 53.28bn | 13.31k | 30.10 | 2.30 | 25.72 | 4.41 | 0.2884 | 0.2884 | 1.96 | 3.77 | 0.4479 | 8.43 | 5.48 | 907,307.90 | 6.60 | 17.68 | 7.70 | 21.32 | 38.81 | 46.89 | 14.73 | 25.63 | 5.27 | 40.48 | 0.035 | 34.54 | -8.04 | 26.60 | -34.47 | 17.52 | 43.13 | -- |
Data as of May 31 2024. Currency figures normalised to Giant Biogene Holding Co Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
E Fund Management Co., Ltd.as of 11 Mar 2024 | 50.07m | 5.03% |
The Vanguard Group, Inc.as of 30 Apr 2024 | 15.14m | 1.52% |
Rosefinch Fund Management Co., Ltd.as of 31 Dec 2023 | 11.31m | 1.14% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 11.20m | 1.13% |
Norges Bank Investment Managementas of 31 Dec 2023 | 8.29m | 0.83% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 5.71m | 0.57% |
BlackRock Fund Advisorsas of 09 May 2024 | 5.01m | 0.50% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 4.23m | 0.43% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 3.42m | 0.34% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 3.32m | 0.33% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.